Vitamin D has long been recognized for its essential role in maintaining healthy bones by helping the body absorb calcium and phosphorus. However, a growing body of research suggests its influence may extend far beyond skeletal health. Scientists are increasingly investigating vitamin D's effects on the immune system, inflammation, cancer treatment outcomes, pain management, and even long-term brain health. Recent studies indicate that maintaining adequate vitamin D levels could provide important health benefits, particularly for people facing serious illnesses such as breast cancer.
One of the most promising findings comes from a Brazilian study examining the impact of vitamin D supplementation during breast cancer treatment. Researchers at São Paulo State University followed 80 women over the age of 45 who were undergoing neoadjuvant chemotherapy, a treatment given before surgery to shrink tumours and improve surgical outcomes. Participants were randomly assigned to receive either a daily vitamin D supplement of 2,000 IU or a placebo.
After six months, the results revealed a notable difference between the two groups. Among women taking vitamin D, 43% experienced a complete pathological response, meaning no detectable cancer remained following chemotherapy. In comparison, only 24% of women in the placebo group achieved the same outcome. This represents an approximately 79% relative improvement in treatment success. Researchers noted that the vitamin D dose used was relatively modest and far below the much higher doses commonly prescribed to correct severe deficiencies.
The study's significance lies not only in its findings but also in the accessibility of the intervention. Many advanced therapies used to improve chemotherapy response can be expensive and unavailable to large segments of the population. Vitamin D, by contrast, is inexpensive, widely available, and generally safe when used appropriately. Most women in the study began treatment with low vitamin D levels, and supplementation successfully increased these levels throughout chemotherapy. Researchers believe vitamin D's ability to regulate immune function and inflammation may contribute to the improved treatment response, although the precise biological mechanisms remain under investigation.
Vitamin D may also play an important role in surgical recovery. Another recent study examined women undergoing modified radical mastectomy for breast cancer and found a strong association between vitamin D deficiency and increased postoperative pain. Conducted at Fayoum University Hospital in Egypt, the study followed 184 women, half of whom were classified as vitamin D deficient.
Researchers monitored pain levels during the first 24 hours after surgery and recorded the amount of pain medication required by each patient. Women with low vitamin D levels were three times more likely to experience moderate to severe postoperative pain than those with sufficient vitamin D. Although none of the patients reported extreme pain, deficient patients consistently reported higher pain scores throughout the recovery period.
The differences in medication use were equally striking. Patients with vitamin D deficiency required slightly higher doses of fentanyl during surgery and significantly more tramadol afterward. On average, deficient patients consumed approximately 112 milligrams more tramadol during the first day of recovery. Because opioids carry risks including nausea, drowsiness, dependence, and addiction, reducing the need for these medications could have meaningful clinical benefits.
Researchers suggest that vitamin D may influence pain perception through its effects on inflammatory pathways and immune system regulation. The study also found higher rates of postoperative nausea among deficient patients. While the research was observational and cannot establish a direct cause-and-effect relationship, it highlights vitamin D status as a potentially modifiable factor that may improve recovery following major surgery.
Beyond cancer treatment and recovery, vitamin D may also have implications for cognitive health and dementia prevention. A long-term study published in 2026 followed 793 adults who were free of dementia at the start of the research. Participants, whose average age was 39, had their blood vitamin D levels measured during midlife and underwent brain imaging approximately 16 years later.
The researchers focused on two proteins commonly associated with Alzheimer's disease and other forms of dementia: tau and amyloid-beta. Elevated tau levels are linked to the formation of neurofibrillary tangles in the brain, one of the hallmarks of Alzheimer's disease. After accounting for factors such as age, sex, and depression symptoms, the researchers found that individuals with higher vitamin D levels in midlife had significantly lower levels of tau protein years later.
Interestingly, vitamin D levels were not associated with amyloid-beta accumulation. This suggests that if vitamin D influences dementia risk, it may do so through pathways related to tau pathology rather than all aspects of Alzheimer's disease. Researchers emphasize that the study demonstrates an association rather than proof that vitamin D directly prevents cognitive decline. Nevertheless, the findings are encouraging because midlife is considered a critical period during which risk factors for dementia may be modified.
Taken together, these studies contribute to a growing scientific consensus that vitamin D is involved in a wide range of biological processes beyond bone health. Adequate vitamin D levels may enhance the effectiveness of chemotherapy, reduce postoperative pain and opioid requirements, and potentially support long-term brain health. These findings are particularly relevant because vitamin D deficiency is common worldwide, affecting millions of people across different age groups and regions.
Vitamin D is produced naturally when the skin is exposed to sunlight and can also be obtained through certain foods and supplements. Despite its availability, many individuals do not maintain optimal levels. Current recommendations generally advise daily intake ranging from 800 to 1000 IU for most adults, though requirements may vary depending on age, health status, and individual risk factors.
While the evidence surrounding vitamin D continues to grow, researchers caution against viewing it as a cure-all. Larger clinical trials are still needed to determine whether supplementation directly causes the observed benefits and to identify the most effective doses and treatment strategies. Nevertheless, the research highlights vitamin D as a low-cost, accessible, and potentially powerful tool that could complement existing approaches to cancer care, recovery, and healthy aging.
Story Sources:
-
Vitamin D Supplementation Improves Pathological Complete Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Randomized Clinical Trial. Nutrition and Cancer, 2025; 77 (6): 648 DOI: 10.10
-
Association between preoperative vitamin D level and postoperative pain in patients undergoing breast cancer surgery: a prospective observational study. Regional Anesthesia, 2026; rapm-2025-107495 DOI: 10.1136/rapm-2025-10749580/01635581.2025.2480854
- Association of Circulating Vitamin D in Midlife With Increased Tau-PET Burden in Dementia-Free Adults. Neurology Open Access, 2026; 2 (2) DOI: 10.1212/WN9.0000000000000057